A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century.
暂无分享,去创建一个
S. Seo | A Paskovaty | J M Pflomm | N Myke | S K Seo | A. Paskovaty | J. Pflomm | N. Myke
[1] R. Recco,et al. Antibiotic control in a municipal hospital. , 1979, JAMA.
[2] R. Echols,et al. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. , 1999, The Journal of antimicrobial chemotherapy.
[3] L. Rice,et al. An Interventional Program to Improve Antibiotic Use , 2003, The Annals of pharmacotherapy.
[4] D. T. Bearden,et al. Impact of Antimicrobial Control Programs on Patient Outcomes , 2003 .
[5] T. Cate,et al. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] D. Malone,et al. Excessive antibiotic use for acute respiratory infections in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] K. Wilson,et al. Documentation of antibiotic prescribing controls in UK NHS hospitals. , 2004, The Journal of antimicrobial chemotherapy.
[8] S. Levy. The antibiotic paradox : how the misuse of antibiotics destroys their curative powers , 2002 .
[9] P. Bossuyt,et al. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. , 1999, The Journal of antimicrobial chemotherapy.
[10] D. Wennberg,et al. Antibiotic Optimization: An Evaluation of Patient Safety and Economic Outcomes , 1997 .
[11] R. Gaynes,et al. Practices to Improve Antimicrobial Use at 47 US Hospitals the Status of the 1997 SHEA/IDSA Position Paper Recommendations , 2000, Infection Control & Hospital Epidemiology.
[12] R. Polk. Optimal use of modern antibiotics: emerging trends. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] J. Ramirez,et al. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. , 2001, Archives of internal medicine.
[14] R. Ramphal,et al. Antibiotic restriction in hospitals associated with medical schools. , 1983, American journal of hospital pharmacy.
[15] P. O'Hanley,et al. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. , 1991, The American journal of medicine.
[16] J. Powers,et al. Trends in antimicrobial drug development: implications for the future. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] Norma Terrin,et al. Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years , 2003, Infection Control & Hospital Epidemiology.
[18] D. Gerding,et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. , 1997, Infection control and hospital epidemiology.
[19] Jeremy M. Grimshaw,et al. Changing Provider Behavior: An Overview of Systematic Reviews of Interventions , 2001, Medical care.
[20] F. Daschner,et al. Influence of an infectious disease consulting service on quality and costs of antibiotic prescriptions in a university hospital. , 2001, Scandinavian journal of infectious diseases.
[21] M. Finland,et al. Usage of antibiotics in a general hospital: effect of requiring justification. , 1974, The Journal of infectious diseases.
[22] Y. Carmeli,et al. Health and economic outcomes of vancomycin-resistant enterococci. , 2002, Archives of internal medicine.
[23] Wertheimer Ai,et al. The defined daily dose system (DDD) for drug utilization review. , 1986 .
[24] I. Gould,et al. Sequential antibiotic therapy for cost containment in the hospital setting: why not? , 2001, The Journal of hospital infection.
[25] S. Cosgrove,et al. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. , 2002, Archives of internal medicine.
[26] J. Gums,et al. A Randomized, Prospective Study Measuring Outcomes after Antibiotic Therapy Intervention by a Multidisciplinary Consult Team , 1999, Pharmacotherapy.
[27] N. Fishman,et al. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] G. Counts. Review and control of antimicrobial usage in hospitalized patients. A recommended collaborative approach. , 1977, Journal of the American Medical Association (JAMA).
[29] T. Clemmer,et al. A computer-assisted management program for antibiotics and other antiinfective agents. , 1998, The New England journal of medicine.
[30] J J Schentag,et al. Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. , 1993, Diagnostic microbiology and infectious disease.
[31] L. Mandell,et al. A multidisciplinary hospital-based antimicrobial use program: Impact on hospital pharmacy expenditures and drug use. , 1996, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[32] R. Gross,et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] M. Struelens. Multidisciplinary antimicrobial management teams: the way forward to control antimicrobial resistance in hospitals. , 2003, Current opinion in infectious diseases.
[34] A. Thébault,et al. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. , 2003, The Journal of hospital infection.
[35] D. Horn,et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. , 1998, JAMA.
[36] Leon G Smith,et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] I. Phillips. Prudent use of antibiotics: are our expectations justified? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] R. Quintiliani,et al. Antibiotic formulary selection. , 1995, The Medical clinics of North America.
[39] V L Yu,et al. Empiric antibiotic selection by physicians: evaluation of reasoning strategies. , 1991, The American journal of the medical sciences.
[40] J. Marr,et al. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. , 1988, The Journal of infectious diseases.
[41] R. Wunderink,et al. Erratum: High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm (Clinical Infectious Diseases (2003) 37 (752-60)) , 2003 .
[42] W. Stamm,et al. Urinary tract infections in women: diagnosis and treatment. , 1989, Annals of internal medicine.
[43] F. Herrmann,et al. Effect of a Comprehensive, Multidisciplinary, Educational Program on the Use of Antibiotics in a Geriatric University Hospital , 2004, Journal of the American Geriatrics Society.
[44] J. Gerberding,et al. Pharmacist involvement in antimicrobial use at rural community hospitals in four Western states. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[45] Michael H. Miller,et al. Sequential Parenteral and Oral Ciprofloxacin Regimen versus Parenteral Therapy for Bacteremia: A Pharmacoeconomic Analysis , 1996, The Annals of pharmacotherapy.
[46] J. McElnay,et al. Use of a treatment protocol in the management of community-acquired lower respiratory tract infection. , 2000, The Journal of antimicrobial chemotherapy.
[47] S. Cosgrove,et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] G Sherman,et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.
[49] David Classen,et al. Implementing Antibiotic Practice Guidelines through Computer-Assisted Decision Support: Clinical and Financial Outcomes , 1996, Annals of Internal Medicine.
[50] R. Drew. Programs promoting timely sequential antimicrobial therapy: an American perspective. , 1998, The Journal of infection.
[51] A. Wong-Beringer,et al. Implementing a program for switching from i.v. to oral antimicrobial therapy. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[52] J. Pflomm. Strategies for minimizing antimicrobial resistance. , 2002, American Journal of Health-System Pharmacy.
[53] I. Gould. A review of the role of antibiotic policies in the control of antibiotic resistance. , 1999, The Journal of antimicrobial chemotherapy.
[54] L. Briceland,et al. Survey of Antibiotic Control Policies in University-Affiliated Teaching Institutions , 1996, The Annals of pharmacotherapy.
[55] M. Huycke,et al. Outcomes of an antimicrobial control program in a teaching hospital. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[56] M. Samore,et al. Evaluation of antibiotic use in a hospital with an antibiotic restriction policy. , 2003, International journal of antimicrobial agents.
[57] W. Bilker,et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] C. Bantar,et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] J. Ramirez,et al. Improving Antimicrobial Use: Longitudinal Assessment of an Antimicrobial Team Including a Clinical Pharmacist , 2004, Journal of managed care pharmacy : JMCP.
[60] P A Gross,et al. Implementing Practice Guidelines for Appropriate Antimicrobial Usage: A Systematic Review , 2001, Medical care.